US EditionRosen Law Firm Encourages Barclays PLC Investors to Inquire About Securities Class Action Investigation
Rosen Law Firm alleges Atara Biotherapeutics overstated FDA approval chances for tabelecleucel amid manufacturing and study issues, seeking investor loss recovery.
- On March 23, 2026, the Rosen Law Firm announced an investigation into potential securities claims against Elauwit Connection, Inc. following the company's disclosure of a revenue-recognition error.
- An February 27, 2026, SEC filing revealed that Elauwit would not rely on previously issued financial statements for the quarter ended September 30, 2025, citing "an error specific to network construction project revenue recognition."
- Rosen Law has recovered over $1 billion for investors since its inception and is led by founding partner Laurence Rosen, named a "Titan of Plaintiffs' Bar" in 2020 by Law360.
- Affected investors can join the prospective class action without serving as lead plaintiff or paying out-of-pocket fees, as Rosen Law prepares the case for filing.
- Investors seeking lead-plaintiff status face court-imposed deadlines to move for appointment, initiating a multi-month legal process that may result in litigation or settlement outcomes.
54 Articles
54 Articles
LoudounTimes.com
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, March 24, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Atara Biotherapeutics, Inc. (NASDAQ: ATRA) between May 20, 2024 and January 9,…
Hastings Tribune
Rosen Law Firm Urges Atara Biotherapeutics, Inc. (NASDAQ: ATRA) Stockholders to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Mar 24, 2026-
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Coty Inc. (COTY) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm - Coty (NYSE:COTY)
ATLANTA, March 24, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Coty Inc. ("Coty") (NYSE:COTY). The lawsuit alleges that Defendants issued false and misleading statements and/or failed to disclose material adverse facts, including allegations that the Consumer Beauty market was underperforming, margins were compressed by increased marketing investments and there was slowing growth in its Prestige fragrance s…
Coverage Details
Bias Distribution
- 72% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
